Australia markets closed

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.02320.0000 (0.00%)
At close: 03:41PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/11/2021
30/11/2020
31/03/2020
31/03/2019
Total revenue
105.063
21.67
0
0
0
Cost of revenue
19.415
12.54
0
-
-
Gross profit
85.648
9.13
0
-
-
Operating expenses
Research development
1,521
1,495
442.56
-
-
Selling general and administrative
4,344
7,133
3,931
144.514
169.529
Total operating expenses
6,418
9,115
4,377
144.514
170.019
Operating income or loss
-6,332
-9,106
-4,377
-144.514
-170.019
Interest expense
0
-
-
0
0.218
Total other income/expenses net
1,780
209.284
-12.275
-22.271
-58.959
Income before tax
-4,549
-8,887
-4,381
-146.783
-230.085
Income tax expense
0
-
-
0
-72.551
Income from continuing operations
-4,549
-8,887
-4,381
-146.783
-157.534
Net income
-4,549
-8,887
-4,381
-146.783
-157.534
Net income available to common shareholders
-4,549
-8,887
-4,381
-146.783
-157.534
Basic EPS
-
-0.16
-0.16
-0.02
-0.04
Diluted EPS
-
-0.16
-0.16
-0.02
-0.04
Basic average shares
-
54,285
27,440
6,035
4,184
Diluted average shares
-
54,285
27,440
6,035
4,184
EBITDA
-
-8,619
-4,374
-146.783
-229.867